다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

OCGN

Ocugen (OCGN)

Ocugen Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:OCGN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/18	05:30	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:OCGN	Ocugen Inc
2024/05/15	19:30	GlobeNewswire Inc.	Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy	NASDAQ:OCGN	Ocugen Inc
2024/05/15	04:54	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCGN	Ocugen Inc
2024/05/14	21:00	GlobeNewswire Inc.	Ocugen Provides Business Update with First Quarter 2024 Financial Results	NASDAQ:OCGN	Ocugen Inc
2024/05/14	20:18	IH Market News	US Futures Remain Steady Amid Wall Street Caution Ahead of April PPI Report	NASDAQ:OCGN	Ocugen Inc
2024/05/14	19:32	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OCGN	Ocugen Inc
2024/05/11	05:15	Edgar (US Regulatory)	Form 8-A12G - Registration of securities [Section 12(g)]	NASDAQ:OCGN	Ocugen Inc
2024/05/11	05:14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCGN	Ocugen Inc
2024/05/11	05:05	GlobeNewswire Inc.	Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock	NASDAQ:OCGN	Ocugen Inc
2024/05/10	20:45	GlobeNewswire Inc.	Ocugen to Present at May 2024 Investor Conferences	NASDAQ:OCGN	Ocugen Inc
2024/05/03	20:30	GlobeNewswire Inc.	Ocugen to Host Conference Call on Tuesday, May 14 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2024 Financial Results	NASDAQ:OCGN	Ocugen Inc
2024/05/02	20:15	GlobeNewswire Inc.	Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress	NASDAQ:OCGN	Ocugen Inc
2024/04/29	19:45	GlobeNewswire Inc.	Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024	NASDAQ:OCGN	Ocugen Inc
2024/04/26	22:05	GlobeNewswire Inc.	UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting	NASDAQ:OCGN	Ocugen Inc
2024/04/26	19:30	GlobeNewswire Inc.	Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting	NASDAQ:OCGN	Ocugen Inc
2024/04/19	20:13	GlobeNewswire Inc.	Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy	NASDAQ:OCGN	Ocugen Inc
2024/04/12	20:30	GlobeNewswire Inc.	Ocugen to Participate in Fireside Chat at the Emerging Growth Virtual Healthcare Equity Conference, Presented by Noble Capital Markets	NASDAQ:OCGN	Ocugen Inc
2024/04/10	20:02	GlobeNewswire Inc.	Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU400—Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication	NASDAQ:OCGN	Ocugen Inc
2024/04/08	19:30	GlobeNewswire Inc.	Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial — First Gene Therapy to Enter Phase 3 with a Broad Retinitis Pigmentosa Indication	NASDAQ:OCGN	Ocugen Inc
2024/04/05	20:02	GlobeNewswire Inc.	Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410—a Modifier Gene Therapy—in Phase 1/2 ArMaDa Study for Geographic Atrophy	NASDAQ:OCGN	Ocugen Inc
2024/04/02	21:00	GlobeNewswire Inc.	Ocugen Provides Business Update with Certain Financials for the Year Ending 2023	NASDAQ:OCGN	Ocugen Inc
2024/04/02	07:08	GlobeNewswire Inc.	Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410ST—a Modifier Gene Therapy—in GARDian Study for Stargardt Disease	NASDAQ:OCGN	Ocugen Inc
2024/04/02	06:43	GlobeNewswire Inc.	Ocugen to Host Conference Call on Tuesday, April 2 at 8:30 A.M. ET to Provide Business Update with Certain Financials for the Year Ending 2023	NASDAQ:OCGN	Ocugen Inc
2024/03/18	19:30	GlobeNewswire Inc.	Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical Officer	NASDAQ:OCGN	Ocugen Inc
2024/03/13	21:00	GlobeNewswire Inc.	Ocugen, Inc. Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410	NASDAQ:OCGN	Ocugen Inc
2024/03/06	21:30	GlobeNewswire Inc.	Ocugen to Present at Investing in Cures Summit	NASDAQ:OCGN	Ocugen Inc
2024/02/28	22:00	GlobeNewswire Inc.	Ocugen Clinical Showcase Webcast Now Available	NASDAQ:OCGN	Ocugen Inc
2024/02/26	22:30	GlobeNewswire Inc.	Ocugen Chairman and CEO to present at Abu Dhabi Family Office Summit	NASDAQ:OCGN	Ocugen Inc
2024/02/23	06:05	GlobeNewswire Inc.	Ocugen, Inc. Announces Dosing Completion of Subjects with Stargardt in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST	NASDAQ:OCGN	Ocugen Inc
2024/02/22	06:05	GlobeNewswire Inc.	Ocugen to Present at 2024 BIO CEO & Investor Conference	NASDAQ:OCGN	Ocugen Inc

검색 관련기사 보기:NASDAQ:OCGN

1 2 3 4 5 6 7 8 9 10 다음 >>

Galileo Acquisition

Kismet Acquisition One

Quick Response Gibraltar

Vontobel Financial Produ...

Tomra Systems (PK)

Greenkraft (PK)

Deutsche Wohnen (PK)

Caisse Depots et Consign...

ABEVL202 Ex:20,25

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관